Medeor Therapeutics

Medeor Therapeutics is a clinical-stage cellular immunotherapy company in San Mateo, California, developing MDR-101, a one-time cell therapy manufactured from a living kidney donor's blood that induces mixed chimerism so HLA-matched transplant recipients can withdraw from lifelong immunosuppression while preserving graft function. The platform originated in roughly two decades of research at Stanford University led by Dr. Samuel Strober. The company completed a Phase 3 registration trial that exceeded its target success rate, and has since suspended operations and is seeking an acquirer to complete the BLA filing. Medeor is a therapeutics developer, not a software company: it publishes no developer portal, API, SDK, or machine-readable specification.

Medeor Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Cell Therapy, and Immunotherapy.

Medeor Therapeutics’ developer surface includes product news and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

5.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0

0 APIs

Company Biotechnology Life Sciences Cell Therapy ImmunotherapyOrgan TransplantHealthcare Clinical Trials Pharmaceuticals

Kin Score

Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0

Composite quality — 5.8/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 3.9 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Surface 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/medeor-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Website

Website

News

News

LinkedIn

Other 1

Properties that don't map to a standard resource type

SecondaryMarketListing

SecondaryMarketListing

Source (apis.yml)

aid: medeor-therapeutics
name: Medeor Therapeutics
description: 'Medeor Therapeutics is a clinical-stage cellular immunotherapy company in San Mateo, California, developing
  MDR-101, a one-time cell therapy manufactured from a living kidney donor''s blood that induces mixed chimerism so HLA-matched
  transplant recipients can withdraw from lifelong immunosuppression while preserving graft function. The platform originated
  in roughly two decades of research at Stanford University led by Dr. Samuel Strober. The company completed a Phase 3 registration
  trial that exceeded its target success rate, and has since suspended operations and is seeking an acquirer to complete the
  BLA filing. Medeor is a therapeutics developer, not a software company: it publishes no developer portal, API, SDK, or machine-readable
  specification.'
url: https://raw.githubusercontent.com/api-evangelist/medeor-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
specificationVersion: '0.20'
created: '2026-08-25'
modified: '2026-08-25'
tags:
- Company
- Biotechnology
- Life Sciences
- Cell Therapy
- Immunotherapy
- Organ Transplant
- Healthcare
- Clinical Trials
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://medeortx.com/
- type: PrivacyPolicy
  url: https://medeortx.com/privacy-policy.php
- type: News
  url: https://medeortx.com/news.php
- type: LinkedIn
  url: https://www.linkedin.com/company/medeor-therapeutics/
- type: SecondaryMarketListing
  url: https://forgeglobal.com/medeor-therapeutics_stock/
- type: DomainSecurity
  url: security/medeor-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-25'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: medeortx.com serves a live homepage whose lead paragraph states Medeor has suspended operations and is seeking an
    acquirer to complete the BLA filing, leaving a clinical-trial archive site with no developer, API, or data surface of
    any kind.
  evidence:
  - url: https://medeortx.com/
    status: 200
  - url: https://medeortx.com/openapi.json
    status: 404
  - url: https://medeortx.com/llms.txt
    status: 404
  - url: https://medeortx.com/.well-known/api-catalog
    status: 404
  - url: https://github.com/medeortx
    status: 404
  checked: '2026-08-25'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/medeor-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/medeor-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/medeor-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.